This brief review summarizes new findings related to the reported beneficial effects of melatonin on reproductive physiology beyond its now well-known role in determining the sexual status in both long-day and short-day seasonally breeding mammals. Of
INTRODUCTION
The discovery of melatonin by Lerner [1] and colleagues in 1958 heralded a new field of research in reproductive physiology. Ever since Huebner [2] reported that a tumor of the human pineal gland altered pubertal development (almost 70 yr before the identification of melatonin), it was surmised that some factor of pineal origin may be capable of influencing reproductive function. This led many scientists in the first half of the 20th century to experimentally examine the association of the pineal with the reproductive status in a variety of species but with limited success in terms of demonstrating a functional relationship [3, 4] . The findings were not sufficiently compelling to convince most, if any, reproductive biologists that the pineal gland and the reproductive system were functionally linked.
Essentially concurrent with the discovery of melatonin, cytological studies [5, 6] of the pineal gland indicated that its metabolic activity was increased during darkness. These observations were soon supported by reports claiming that the activity of one of the enzymes that is required for melatonin synthesis (i.e., hydroxyindole O-methyltransferase, now called acetylserotonin O-methyltransferase) was supposedly higher in the pineal at night than during the day [7] . With the commercial availability of melatonin and the knowledge that the gland was presumably stimulated during darkness, scientists could then more properly design studies to examine the potential involvement of the gland in reproductive biology. These newly designed experiments quickly revealed that the exposure of a photosensitive rodent, the Syrian hamster, to short days [8, 9] or the daily administration of melatonin to rats [10] changed the function of the pituitary-gonadal axis and, moreover, convinced the scientific community of the legitimacy of the pineal gland as an organ of internal secretion involved in the regulation of reproductive function, particularly in seasonal breeders.
HISTORICAL PERSPECTIVE OF THE PINEAL GLAND, MELATONIN, AND SEASONAL REPRODUCTION
Much of the research related to melatonin and the pineal gland in the first 30 yr after the discovery of the indole was related to its ability to modulate reproductive physiology in photoperiod-dependent seasonally breeding mammals [11] [12] [13] [14] . Long-day breeding animals (e.g., many rodents) are sexually depressed during the winter months (when elevated melatonin levels are at their longest nocturnal duration), with the reproductive quiescent period being prevented by surgical removal of the pineal gland. Because reproductive regression was associated with the extended period of melatonin elevation, the terms antigonadal or antigonadotrophic were commonly applied to melatonin. This is now known to be an erroneous classification of melatonin inasmuch as many shortday breeders (e.g., several breeds of sheep, white-tailed deer, etc.) actually are sexually most active and capable during the shortest days of the year, when melatonin levels are maximal in terms of their nocturnal duration [15] [16] [17] . In these species, melatonin could thus be referred to as being progonadotrophic.
Obviously, melatonin is per se neither antigonadotrophic nor progonadotrophic. Rather, the changing duration of the nocturnal melatonin message is a passive signal that provides the hypothalamo-pituitary-gonadal axis information as to the time of year (i.e., calendar information) [18] . The reproductive organs of both male and female Syrian hamsters maintained under naturally occurring short days and reduced temperatures normally experience winter gonadal regression unless the pineal gland is surgically removed (and the nocturnal rise in melatonin is averted) [19] . The reproductive axis obviously uses the seasonally dependent melatonin rhythm to adjust testicular and ovarian physiology accordingly. In this scheme, the time of year at which a given species can successfully mate is determined by the duration of the gestational period and ensures that the offspring are born when environmental temperatures are becoming warmer and food availability is increasing (i.e., the spring and early summer). Thus, the actual mating time is less important than the birthing time, and seasonally breeding species use the time-of-year signal, as manifested by the changing duration of the nocturnal melatonin message, to ensure birth of the young in the spring [20] .
To further illustrate the importance of day length in determining reproductive capability in seasonal breeders, it is documented that the absolute duration of the nocturnal melatonin rise is the major, if not the exclusive, determinant relevant to the induction of sexual activity and quiescence [21, 22] . Thus, when Syrian hamsters are maintained under shortwinter but increasing day lengths after the winter solstice (when the nocturnal melatonin rise is of long duration but is becoming shorter on a nightly basis), involution of the reproductive system still occurred [23] . With prolonged short-day exposure (equivalent in duration to winter days), the neuroendocrine-reproductive axis of the Syrian hamster becomes refractory to short days, a phenomenon referred to as photorefractoriness.
It is universally accepted that seasonal collapse and recrudescence of the gonads of photoperiodically sensitive mammals, whether they are long-day or short-day breeders, are dependent on the annual fluctuations in day and night lengths, which determine the interval of the nocturnal melatonin rise (Fig. 1 ) [24] [25] [26] . The photoreceptors that mediate these precisely timed reproductive events are highly specialized retinal ganglion cells that contain a unique photopigment, melanopsin [27, 28] . These cells convey information about day and night length via the retinohypothalamic tract to the biological clock (the suprachiasmatic nuclei [SCN] ) in the anterior hypothalamus [29, 30] . The SCN then send the information to the pineal gland via central and peripheral sympathetic neurons [31, 32] . By releasing norepinephrine to the pinealocytes on a nightly basis, the neurons regulate the nocturnal elevation in melatonin production [33] . If the sympathetic innervation to the pineal gland is destroyed (e.g., by bilateral superior cervical ganglionectomy), nocturnal melatonin production does not occur, and the gland is no longer capable of regulating reproductive physiology [11] ; thus, these animals become continuous breeders, a situation that would be a major detriment to animals living under naturally varying environmental conditions.
In the Syrian hamster, daily afternoon melatonin injections, even when the animals are under long-day conditions (!14L per day), cause reproductive atrophy and hormonal changes similar to those induced by short-day exposure [20] . As with photorefractoriness, melatonin-treated hamsters eventually become refractory to the daily melatonin administration, and the gonads spontaneously regenerate. From this, it can be inferred that photorefractoriness is due to a loss of sensitivity to melatonin.
The cellular and molecular mechanisms whereby melatonin intervenes at the level of the neuroendocrine axis to modulate the secretion of pituitary gonadotropins and prolactin are being unraveled [34] [35] [36] , including the cellular receptors that mediate the effects of melatonin [37] [38] [39] . Although these and other studies already cited [17, [24] [25] [26] have elegantly demonstrated some of the complex mechanisms whereby melatonin may modulate reproductive function, the definitive processes have escaped detection. What is apparent is that the actions of melatonin occur at multiple levels and include hypothalamic, adenohypophyseal, and end-organ sites. Although few species have been used for these studies, it is presumed that the definitive mechanisms will be similar for many mammalian species when they are uncovered.
Investigations using both long-day and short-day breeders have obviously contributed significantly to the understanding of the mechanisms whereby day length and melatonin govern seasonal reproduction. As a result of these findings, melatonin has been successfully used as a pharmacological agent to advance the breeding season of sheep and to induce estrous cycles and increase lambing during the interval when these animals would normally be experiencing seasonal anestrus [40] [41] [42] . These actions of melatonin are positive and are associated with an improvement of the ovulation rate [43] , enhanced luteal function [44, 45] , and greater embryo viability [46, 47] .
Although the information that relates the pineal gland and melatonin to seasonal reproduction has accumulated over several decades, other actions of melatonin that seem to be beneficial in terms of reproductive efficiency have only recently been uncovered. Those functions of melatonin are summarized in the subsequent sections of this review.
MELATONIN AND SELECTION OF A SEXUAL MATE
Some notable new findings suggest that melatonin may have a role in the selection of a sexual partner. Bertrand and colleagues [48] observed that administering melatonin (50 lg/ ml) to male zebra finches (Taeniopygia guttata) in the drinking fluid in combination with carotenoids (100 lg/ml) enhanced the brightness of the carotenoid-based pigmentation in their bills. Given that males with brighter colored bills (assessed using a Dulux Trade [Slough, Berkshire, England] color chart) are more likely to be selected as a mate by a female zebra finch, melatonin may aid in the selection of a mate. Like melatonin [49, 50] , carotenoids are free radical scavengers and antioxidants [51, 52] . To protect against oxidative stress, nonpigmentary melatonin in zebra finches is possibly used preferentially in the detoxification of radicals over the carotenoids, leaving the latter available to deposit in the bill and thereby improving its color and enhancing the chance of that male being selected as a sexual partner.
In the study by Bertrand et al. [48] , the amount of drinking fluid consumed by the finches was not measured, so the daily intake of melatonin could not be calculated. Although it seems likely that the quantity of melatonin consumed would have caused pharmacological levels in the blood of the birds, this remains unknown without information on the amount normally absorbed from the gastrointestinal tract of the zebra finch. Had plasma levels of melatonin been measured, an answer to the issue of pharmacological and physiological levels could likely have been obtained. There are wide variations in melatonin concentrations in different fluids [53, 54] , so what is a pharmacological level in one fluid is a physiological level in another.
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Given its actions beyond those as a reducer of oxidative stress, it is also possible that melatonin may influence bill color by means that do not directly involve preservation of the carotenoids (e.g., its effects on metabolism or the immune system, as discussed elsewhere [48] ). Nevertheless, if pigmentation of the bill underlies sexual attractiveness [55] , the final effect of melatonin would be the same.
Melatonin could theoretically assist in determining the selection of a sexual partner by finches in another way. Melatonin receptors were identified in neurons of two central sensorimotor areas (nucleus hyperstriatalis pars caudale and nucleus robustus archistriatalis) of the descending song control circuit that are essential for the song pattern of male zebra finches [56] . Melatonin receptors were identified in the peripheral hypoglossal nuclei, which are likewise part of the song circuit. When melatonin was applied to brain slices containing neurons of the nucleus robustus archistriatalis of the song control circuit, the firing rate of the neurons was suppressed, suggesting that melatonin may alter the singing ability of the bird. When a melatonin receptor antagonist (S 20928) was systemically administered in vivo to male finches at the beginning of the night just before the nocturnal melatonin rise, it shortened both the song and the motif length and influenced the song syllable lengths the following day. However, the temporal pattern of singing was not altered, indicating that the disrupted song produced by the melatonin receptor antagonist was not merely a circadian disturbance. Given that female finches are attracted by long song and motif lengths, these data are the first to imply that melatonin may have a role in male courtship behavior. The findings are notable because the ability of the male to sing makes it a preferred partner for sexual activity [57] . In this study, it was FIG. 1. The light and dark regulation of the biological clock (suprachiasmatic nucleus), pineal melatonin production, and seasonal reproduction in photoperiodic mammals. Specialized photoreceptive cells in the retinas (melanopsin-containing ganglion cells) mediate the effects of light (450-490 nm) on the biological clock and melatonin production. The circuitous neural connections between the eyes and the pineal gland (pinealocyte) are shown. At night, the postganglionic sympathetic neurons ending in the pineal gland release norepinephrine, which activates primarily b-adrenergic receptors to stimulate a cascade of molecular events that culminate in melatonin production and release. Seasonally changing photoperiods alter the duration of elevated nocturnal melatonin production, a signal that provides mammals with the time-ofyear information. This message determines the breeding season of both long-day and short-day breeders. In both cases, the young are characteristically delivered in the spring or early summer. ASMT, acetylserotonin Omethyltransferase; HIOMT, hydroxyindole O-methyltransferase; NAT, alkylamine Nacetyltransferase.
difficult to test the effect of melatonin directly in vivo because endogenous melatonin is available nightly. To circumvent this, the investigators would have had to have pinealectomized the birds. In lieu of this, they administered a membrane melatonin receptor blocker.
In fish, physiological color changes for the purpose of attracting mates is commonplace. Sköld and coworkers [58] investigated the mechanisms governing nuptial coloration in the two-spotted goby (Gobiusculus flavescens). Female gobies develop an orange belly that acts as an ornament to attract members of the opposite sex; the color is a consequence of the pigmentation of the gonads in combination with chromatophore-rich pigmentation and transparency of the skin. The pigmentation can change rapidly, and when the bright color is on the background of the darker surrounding skin, the belly appears to glow. When skin explants of gobies were treated with a combination of either melatonin and melanocytestimulating hormone or melatonin and prolactin, the orange coloration and transparency of the belly skin were exaggerated. The authors noted that this duplicates the chromatic glow that accompanies courtship. The nuptial coloration change induced by melatonin and other hormones would presumably benefit the individual in terms of attracting a sexual mate. While the findings by Sköld et al. are consistent with the hypothesis that melatonin and other hormones are relevant to sexual selection, their investigations were performed on belly skin explants; whether this translates into the same function for those hormones in vivo remains to be tested.
The zebra finch and the goby are only two of the numerous species that use ornamental pigmentation to attract a mate. Colorful plumage generally signals superior genetic quality and is a common ploy used by many bird species as a sexual attractant [59] , while bright pigmentation of certain body areas serves this purpose in some reptiles, amphibians, and mammals. On the basis of the studies already summarized, it may be worthwhile to examine more broadly the role of melatonin in the extravagant pigmentary changes that serve as a sexual enticement and represent genetic quality in a variety of species. There is ample precedent for melatonin's working at the level of the integument. Melatonin receptors exist in mammalian skin and hair follicles [60, 61] , and the indole modulates hair growth, pigmentary changes in fur, and molting in many mammalian species [60] , as well as scale growth in fish [62] . Because crypsis and mimicry both require clever skin or hair pigmentary adaptations, melatonin could be examined relative to these physiological changes as well.
MELATONIN AND REPRODUCTIVE OXIDATIVE STRESS
In 1993, melatonin was discovered to function as a direct free radical scavenger when it was shown to detoxify the highly reactive hydroxyl radical (OH) in vitro [63] . Since then, more than 1000 publications have confirmed the ability of melatonin and its metabolites to reduce oxidative stress in vivo [64] [65] [66] . In these investigations, melatonin was found to scavenge both oxygen-and nitrogen-based reactants [49, 50] in several subcellular organelles [66] [67] [68] and to stimulate antioxidative enzymes (Fig. 2) [69, 70] . These functions of melatonin as a ubiquitously acting antioxidant have implications for the optimal function of cells and organs, including those of the reproductive system [71, 72] . Although the direct free radical scavenging actions of melatonin are accomplished without an interaction with specific receptors, the stimulatory effects of melatonin on antioxidative enzymes are likely mediated either by membrane receptors or by nuclear-or cytosol-binding sites [73] . Melatonin receptors have been identified in hypothalamic neurons governing the release of pituitary gonadotrophs [74, 75] , in gonadotropins of the anterior pituitary [76, 77] , and in both female and male gonads [78, 79] , as well as in the reproductive adnexae [80, 81] .
Melatonin concentrations in human ovarian follicular fluid (FF) obtained from the antra of Graafian follicles are
Reactants that cause nitro-oxidative stress are shown. The oxygen-based reactants are in red, while the nitrogenbased reactants are in blue. The green box identifies a chlorine-based reactant, hypochlorous acid (HOCl). Melatonin is reported to directly scavenge the reactants marked with an asterisk. Of these, the most reactive agents are the peroxynitrite anion (OONO À ) and the hydroxyl radical (OH). In addition to scavenging a number of radicals and their derivatives, melatonin has been shown to stimulate (") a number of antioxidative enzymes, including glutathione peroxidase (GPx), glutathione reductase (GRd), and superoxide dismutase (SOD). In addition, melatonin has been shown to increase the levels of another important antioxidant (glutathione [GSH] ) by stimulating its ratelimiting enzyme, glutamylcysteine ligase (GCL). Finally, there are reports that melatonin inhibits the pro-oxidative enzymes nitric oxide synthase (NOS) and myloperoxidase (MPO) [64] [65] [66] 448 significantly higher than those in simultaneously collected plasma samples [82, 83] . As in some other body fluids, melatonin in the FF may be concentrated against a gradient, or it may be synthesized at a yet unknown site in the ovary (possibly the granulosa cells) and released into the FF [84] . Among the proposed functions of melatonin in the FF is the possibility that, via its antioxidative actions, melatonin reduces apoptosis of critical cells and allows preovulatory follicles to fully develop and provide mature oocytes for ovulation [72] .
That melatonin reduces oxidative mutilation of essential molecules in oocytes was recently reported by Tamura et al. [85] . This group measured human FF melatonin concentrations sampled during oocyte retrieval for the purpose of in vitro fertilization and embryo transfer (IVF-ET) and correlated these levels with the amount of 8-hydroxy-2-deoxyguanosine (8-OHdG), a product of free radical damage to DNA, in the oocyte samples. The 8-OHdG levels were used to judge the degree of degeneration of the oocytes. This study revealed an inverse correlation between the FF melatonin concentrations and the amount of 8-OHdG in oocytes, suggesting that melatonin in the FF diffuses into the cumulus oophorus and oocytes to protect them from free radical damage.
To further document an association between melatonin and ovarian oxidative stress in the study by Tamura et al. [85] , 18 women who had failed to become pregnant in a previous IVF-ET cycle were treated with 3 mg of melatonin, 600 mg of vitamin E, or both daily from Day 5 of the previous menstrual cycle until the day of oocyte retrieval. Intrafollicular concentrations of 8-OHdG and hexanoyl-lysine adduct, a damaged lipid product, were evaluated as biomarkers of oxidative stress. At a 200-fold larger dose than melatonin, melatonin and vitamin E reduced DNA and lipid damage to the same degree. The combination of the two antioxidants did not further lower oxidatively damaged products in the FF. Intrafollicular concentrations of melatonin rose from 112 pg/ml in the control FF to 432 pg/ml after daily indole treatment. The potential actions of melatonin at the follicular level are summarized in Figure 3 .
To evaluate the clinical usefulness of melatonin in IVF-ET, 56 women were treated with melatonin (as already described), and 59 women were left untreated [85] . When recovered oocytes were used in the IVF-ET procedure, melatonin was found to double both the fertilization and pregnancy rates compared with those from women not treated with melatonin (Table 1) . Considering the normally low success rate of fertilization and implantation during IVF-ET, melatonin should be further tested as a treatment in women undergoing this procedure. These findings are particularly notable when the markedly different amplitudes of the endogenous melatonin peak are compared among women [86] . A woman with a greatly attenuated melatonin peak may perhaps be at increased risk for giving birth to a child with a specific pathology (e.g., Down syndrome, spina bifida, etc.) because the oocyte had been oxidatively damaged.
Melatonin also may have utility as a treatment for women who are near the end of their reproductive age and want to become pregnant. A number of investigations have reported that endogenous levels of melatonin are reduced with increasing age [87] ; predictably, the likelihood of oxidative damage in all cells, including the oocyte, may be elevated. However, there is some disagreement as to whether endogenous blood levels of melatonin fall at all [88] in the aged or whether the drop is secondary to the prescription drugs many older people are taking; especially important in this regard are b-adrenergic blockers (e.g., propranolol), which interfere with the ability of norepinephrine released from the postganglionic sympathetic neurons in the pineal gland to induce melatonin synthesis [89] . While this issue remains unresolved in humans, advanced age in drug-free rats [90] and Syrian hamsters [91] is associated with marked reductions in pineal melatonin production. If melatonin levels decrease with age, whether spontaneous or due to drug use, the reproductive system may exhibit increased susceptibility to oxidative damage because of the loss of this antioxidant.
In mouse as in human, exogenously added melatonin directly protects oocytes from oxidative stress. When mouse oocytes were incubated with the oxidant hydrogen peroxide (H 2 O 2 ), increasing concentrations led to a progressively greater percentage of the oocytes failing to mature (development of the first polar body) [85] . On the other hand, when increasing amounts of melatonin were added to the incubation medium in combination with H 2 O 2 , oocytes exhibited a dose-response increase in oocyte maturation (Fig. 3) . The result of this study is reminiscent of findings reported by Voznesenskaya et al. [92] , who reported that melatonin also protects mouse oocytes from failure due to experimental manipulation of the immune system. Likewise, oocyte and early embryo development in the buffalo [93] , cow [94] , and pig [95] benefits from melatonin as well.
The protective effects of melatonin against toxic free radicals may also be manifested at the time of normal ovulation. The shedding of oocytes from a Graafian follicle involves processes similar to a local inflammatory response in the wall of the follicle [96] . As a consequence, both reactive oxygen species (ROS) and reactive nitrogen species (RNS) are produced in excess by local inflammatory cells, increasing the likelihood that the oocyte could be oxidatively abused. Given that melatonin and its metabolites effectively reduce molecular damage due to ROS and RNS [63-66, 97, 98] , the high endogenous concentrations of melatonin in the FF may serve to protect both the oocytes and the steroid-secreting granulosa cells from toxic oxygen-and nitrogen-based byproducts. Collectively, the data published within the past 2 yr argue favorably that melatonin has a positive effect on processes related to ovulation and early embryo development and that the levels of melatonin in the mature Graafian follicle, which exceed those in the plasma, are important for the optimal development of oocytes and their release from the ovaries. These beneficial actions may relate in part to the direct free radical scavenging actions of melatonin, processes that are receptor independent, or they may in some cases also involve melatonin receptors, which are known to be present in some ovarian cells [93] .
Male sperm may be protected from oxidative damage by melatonin or its metabolites. Diazinon is a widely used organophosphorus pesticide that is toxic to sperm via free radical mechanisms. Exposure of any species to this toxin compromises spermatogenesis. Given that melatonin has been found to be protective against many other free radicalgenerating toxic molecules [99] , it was speculated that it may also protect sperm from diazinon toxicity. In both the earthworm (Eisenia foetida) [100] and mouse [101] , melatonin treatment preserved spermatogenesis that was interrupted due to diazinon exposure. Under other conditions in which testicular free radical generation is accelerated, melatonin markedly reduces the level of gonadal oxidative stress [101, 102] . This is consistent with numerous observations about other tissues showing that free radical-mediated damage due to toxin exposure or resulting from other processes is attenuated if melatonin is provided [49, 50, 66, 103, 104] .
For mammalian spermatozoa to be capable of fertilizing an oocyte, they must be capacitated and thereafter undergo an acrosome reaction and hyperactivation. Hyperactivation is a specialized movement of the flagellum of the sperm that permits it to penetrate the zona pellucidum. Because human seminal fluid contains melatonin [105] and spermatozoa reportedly possess membrane melatonin receptors [106] , Fujinoki [107] investigated whether melatonin would influence hyperactivation of hamster sperm. The addition of nighttime serum melatonin concentrations (1 nM) to sperm resulted in significant hyperactivation within 1-2 h; this response was inhibited by the addition of the MTNR1A/MTNR1B melatonin receptor antagonist luzindole to the incubation medium, while the addition of specific MTNR1B antagonists was incapable of altering the hyperactivation response to melatonin. Because of this, the author surmised that the ability of melatonin to modify this aspect of sperm motility involved the MTNR1A receptors and, moreover, was related to the negative effect of melatonin on the production of nitric oxide. The ability of melatonin to stimulate flagellar motility is important given that this response is a requirement for the successful penetration of the zona pellucidum and fertilization of the egg. In contrast to the findings in hamster sperm reported by Fujinoki, Bomman, and colleagues [105] also compared the level of melatonin with the degree of sperm motility when they initially measured melatonin levels in human seminal fluid. On the basis of their observations, this group concluded that physiological melatonin concentrations in the seminal fluid did not correlate with sperm motility. Further studies are needed to clarify the role of melatonin in sperm activation and function in humans and other species.
Because human births occur more frequently at night (when melatonin levels are at their maximum) than during the day, Schlabritz-Loutsevitch et al. [108] speculated that the two events may be related and that myometrial cells would likely possess melatonin receptors. With the aid of human uterine biopsy specimens, RT-PCR, and in situ hybridization methods, they showed that both MTNR1A and MTNR1B membrane receptors are present on myometrial cell membranes and that they are Gi protein linked to adenylate cyclase, as in many other cells. These receptors are also present in rat myometrial cells [109] . In myometrial cells collected from women during labor, the expression levels of the MTNR1B melatonin receptor are markedly upregulated. Moreover, in these cells the actions of melatonin synergize with those of oxytocin to promote muscle contractions and gap junction activity that is important in the coordination of myometrial contractions [110] . These observations were made on cultured uterine cells; if they also occur in vivo, the interactive effects of oxytocin and melatonin would promote coordinated and forceful myometrial contractions that would enhance successful parturition. 
MELATONIN AND THE PATHOPHYSIOLOGY OF PREGNANCY
Several diseases and conditions that occur as a result of pregnancy may benefit from melatonin treatment. Of particular note in this regard is preeclampsia, a major disorder that develops in an estimated 5%-7% of all pregnancies worldwide. Major signs include increased elevated systolic and diastolic blood pressures and proteinuria that occur during the second half of pregnancy [111] . Complications of preeclampsia develop in both the mother and fetus. Maternal complications include renal or liver failure, cerebral edema with seizures, HELLP syndrome [hemolysis, elevated liver enzymes, and thrombocytopenia], and (rarely) death. In the fetus, the most frequent complications include low birth weight, prematurity, and death.
Preeclampsia is a condition of elevated oxidative stress with high free radical generation and reduced antioxidants. The placenta is believed to be a major source of free radicals and lipid peroxidation products that are transported to distant sites, leading to systemic oxidative stress [112] . At 33 wk of gestation, women with severe preeclampsia were found to have lower nighttime serum melatonin levels than those with mild or no preeclampsia [113] . Given the antioxidant properties of melatonin (Fig. 2) , its use may be helpful in reducing the systemic oxidative stress associated with preeclampsia. In addition, it may reduce placental free radical damage, as suggested by the findings of a study by Milczarek and coworkers [114] . Also, melatonin has antihypertensive [115] and anticonvulsive [116] actions, which would make it beneficial in preeclampsia. Although the association between FIG. 4. Top: Some of the proposed functions of melatonin in the Graafian follicle. Melatonin, and several of its metabolites are scavengers of ROS and RNS. Moreover, melatonin promotes the expression and activities of several antioxidative enzymes (SOD, GPX, and GSR), while inhibiting the activity of the pro-oxidative enzyme nitric oxide synthase (NOS). Melatonin has been reported to reduce a damaged DNA product (8-OHdG) and a product resulting from the oxidation of lipids (hexanoyl-lysine adduct) in the FF. The level of oxidatively damaged molecules in the FF directly correlates with the quality of the ovum. Melatonin has been shown to stimulate maturation-inducing hormone (MIH [17}, 20 b-dihydroxy-4-pregnen-3-one]), which promotes maturation of the oocyte [71, 72] . Additional details related to these events are summarized in the text. Many of the proposed functions are related or overlap. Bottom: Potential functions of melatonin during pregnancy. Melatonin readily crosses the placenta to enter the fetal circulation. The day and night variation in melatonin levels provides the fetal SCN with light and dark information. Melatonin has been found to protect the fetus from oxidative stress due to ROS and RNS [126] . This indole may also enhance progesterone (P) synthesis by the corpus luteum (and later by the placenta) to assist in the maintenance of pregnancy, while inhibiting the premature release of oxytocin. In the placenta, melatonin has similar protective effects against nitrooxidative stress. Several investigators have proposed the use of melatonin to reduce the severity of preeclampsia and associated alterations [114, 127] . Although the details of the actions of melatonin in the ovary and uterus are limited, the experimental data published to date indicate the likelihood of its improving the microenvironment of both organs [71, 85] . IUGR, intrauterine growth retardation. melatonin use and preeclampsia has not been thoroughly tested, its use as a treatment has been suggested [117] .
As with any other organs, the reproductive system is subject to ischemia-reperfusion damage in the event of a transitory interruption of the blood flow. Given the contribution of free radicals and related reactants to the molecular and cellular destruction that accompanies ischemia-reperfusion, many investigators have studied the ability of melatonin to attenuate the tissue injury resulting from anoxia or hypoxia that is followed by the reflow of oxygen-rich blood into the tissue. The outcomes of these studies [118] [119] [120] [121] [122] documented the benefits of melatonin in many organs by reducing what is referred to as ischemia-reperfusion injury. Similar studies (discussed in the next paragraph) on reproductive organs have confirmed the benefits of melatonin in resisting oxidative and nitrosative stress resulting from temporary ischemia-reperfusion.
Placental infarction leads to fetal growth retardation [123] . Realizing the potential utility of melatonin in treating this condition, Okatani et al. [124] examined the effects of melatonin on placental mitochondrial physiology and the levels of oxidative stress following a 20-min interval of bilateral occlusion of the utero-ovarian arteries with a 1-h period of restored blood flow. The end points included the placental mitochondrial respiratory control index (RCI [an estimate of the total respiratory chain activity]), the ratio of added ADP:consumption of oxygen during state 3 respiration (ADP:O 2 ), and the placental concentration of products of lipid peroxidation (thiobarbituric acid reactive substances [TBARS] ). The RCI and the ADP:O 2 ratio collapsed as a consequence of ischemia-reperfusion, while TBARS rose markedly. Given in advance of the ischemic episode, melatonin counteracted all the changes.
Because the placenta readily transfers melatonin from the maternal to the fetal circulation (Fig. 4, bottom) [125] and given that a damaged placenta would likely transport the indole less efficiently than a healthy one, the finding that melatonin preserves the integrity of this tissue may well have implications for protection of the fetus as well. Indeed, when pregnant rats whose fetuses were subjected to ischemia-reperfusion injury due to clamping of the utero-ovarian arteries were given melatonin, the indole rescued the brain of the fetuses from the extensive oxidative damage that normally results from ischemia-reperfusion [126] .
More recently, an extensive study [127] documented the capability of melatonin in protecting the placenta from both oxidative and nitrosative stress. In this study, placental and fetal ischemia was achieved by interrupting the blood flow through the utero-ovarian arteries of Wistar rats at Day 20 of pregnancy. Vascular clamping that was followed by the release and reflow of oxygenated blood caused a reduction in the weight of the placenta and a reduced mitochondrial RCI, while it exaggerated the placental levels of 8-OHdG, an oxidatively damaged DNA product, and elevated levels of apurinic/ apyrimidinic endonuclease 1 (APEX1), also known as redox factor 1. APEX1 functions in repair of DNA in the rat placenta and typically rises under conditions of elevated oxidative and nitrosative stress. When pregnant rats were given melatonin orally during the interval of ischemia-reperfusion, the degree of placental damage was less severe based on all measured parameters.
The placenta is damaged by other means that also involve free radicals. Thus, obstructive cholestasis (OC) in the mother during pregnancy negatively alters the function of the placenta and the fetal liver and may in fact cause death of the fetus. This experimental procedure was used to test the protective actions of melatonin in both of these tissues [128] . The OC was achieved by ligating the common bile duct in the last one third of pregnancy in rats. Thereafter, half of the animals were given melatonin intragastrically. Melatonin reduced the upregulation of apoptosis-related processes (i.e., caspase 3 activity and BAX alpha) in the placenta and fetal liver, which were apparent in rats experiencing OC only. In addition, melatonin upregulated proteins involved in cellular protection against oxidative stress; these included biliverdin IX alpha-reductase and the sodiumdependent vitamin C transport protein SVCT2 (official symbol, SLC23A2) in both fetal liver and placenta. Given that melatonin, even in massive doses, has no fetal or maternal toxicity [129] , the use of this indole in situations in which the placenta and fetus may be harmed by free radicals is deserving of more extensive examination, including in the human.
At the time of delivery of newborns, an infrequent but serious complication is fetal asphyxiation resulting from a transitory interruption of the blood supply that is followed by the reestablishment of the blood flow (i.e., ischemia-reperfusion injury). The most devastating complications associated with this condition are irreversible brain damage due to excessive oxidative and nitrosative cellular damage and death. Fulia and colleagues [130] treated 10 newborns diagnosed as having perinatal asphyxia within 6 h after birth with melatonin (total of 80 mg given orally over a 16-h period) and compared the results with those of 10 asphyxiated newborns not given melatonin. Compared with the non-melatonin-treated and normally delivered newborns, melatonin administration reduced blood levels of malondialdehyde and nitrite/nitrate, which are both indices of elevated oxidative stress, by roughly 50% (at 12 and 24 h after initiation of melatonin treatment). Three of 10 asphyxiated newborns not given melatonin died, while none of 10 treated with melatonin died. Although it is difficult to determine if the severity of asphyxiation was identical between the two groups of newborns, the results strongly argue for further testing of melatonin to treat newborns experiencing perinatal asphyxia, as well as in other conditions associated with excessive free radical generation. Some of the proposed and possible functions of melatonin at the level of the Graafian follicle and the gravid uterus are summarized in Figure 4 . The publications on which these assumptions are based are reviewed in the preceding paragraphs. An objective of this review is to encourage investigators to further examine the associations that are suggested in the figure, as they could have a significant effect on improving reproductive function if they prove to be valid.
IS MELATONIN A PHYSIOLOGICAL OR PHARMACO-LOGICAL ANTIOXIDANT?
One aspect of any consideration of melatonin as a free radical scavenger and antioxidant in the reproductive system, or in any organ, is whether it is physiologically or only pharmacologically relevant in this regard. For any antioxidant, this is not always easy to determine. All organisms typically accumulate oxidatively damaged molecular debris on a daily basis. This means that the combination of all endogenous antioxidants (e.g., vitamins C and E, b-caratene, uric acid, etc.) working in concert is incapable of preventing even ''physiological'' levels of oxidative damage. Relative to this, it has been reported that long-term pinealectomy, which eliminates the nocturnal rise in melatonin, causes more rapid accumulation of free radical-damaged molecules in several organs of rats [132] . This is consistent with endogenous physiological concentrations of melatonin contributing to the total antioxidative capacity of the organism. Additional studies of this type with 452 the same outcome would bolster the argument that melatonin is a physiologically relevant antioxidant.
To test the ability of any so-called antioxidant to protect against free radical damage, it is commonplace to impose a treatment (e.g., ischemia-reperfusion, hyperoxia, toxic drug administration, etc.) that markedly elevates oxidative stress. Thus, these treatments cause the production of massive (pharmacological) numbers of radicals. To reduce such damage, pharmacological levels of an antioxidant must likewise be administered. In essentially all studies in which melatonin has been compared with classic antioxidants in terms of their relative abilities to reduce such exaggerated oxidative damage, melatonin has been found to be equivalent to, and in many cases more effective than, the other antioxidants in providing protection [133] [134] [135] [136] or in reducing free radicals [137] . Each of the antioxidants used was necessarily provided in pharmacological doses.
An issue regarding the potential role of melatonin as an antioxidant is whether there are sufficient melatonin molecules within cells to successfully compete with other direct free radical scavengers. For example, glutathione is often in millimolar concentrations intracellularly [138, 139] ; this level is much higher than other antioxidants, including melatonin, normally achieve. If the concentration of an antioxidant was of exclusive importance, then only the scavenger at the highest intracellular level would reduce free radical damage. However, the total intracellular concentration is not the sole determinant of the efficacy of a radical scavenger. Antioxidants have different solubilities (e.g., lipid, aqueous, etc.), so they are not uniformly distributed within subcellular compartments [140] [141] [142] . Likewise, free radical generation does not occur uniformly within cells [67, 143] . The important concentration of an antioxidant is the one in the immediate vicinity where a free radical is produced (e.g., within mitochondria, where toxic oxygen derivatives are abundant). Little is known of the subcellular distribution of melatonin; however, as already noted, it effectively competes at equimolar or lower concentrations with other antioxidants in the attenuation of induced oxidative stress [133] [134] [135] [136] [137] .
Considering the state of this research, it is impossible to categorically conclude that melatonin is a physiologically relevant antioxidant. On the other hand, it is highly effective in combating oxidative molecular destruction when given in situations in which free radical production is exaggerated [65, 68, 103, 104, 144] .
To prevent injury to the reproductive system from free radicals in conditions such as preeclampsia in which elevated levels of oxidizing agents are generated, pharmacological doses of antioxidants will need to be administered if benefits are to be achieved. In relation to this, melatonin (particularly in the short term) has a very low toxicity profile (even during pregnancy) [129, [145] [146] [147] [148] and could find use in the treatment of preeclampsia and in other high free radical-related conditions that compromise the normal physiology of the neuroendocrinereproductive axis.
CONCLUSIONS AND PERSPECTIVES
Clearly, melatonin is no longer only applicable to the regulation of seasonal reproductive events in photoperioddependent long-day and short-day breeding mammals. The discovery of melatonin as a direct free radical scavenger and an indirect antioxidant has greatly broadened the mechanisms whereby the indole benefits reproductive physiology. The new findings regarding the potential role of melatonin in mate selection due to its ability to enhance sexual and ornamental pigmentation represent a nascent and developing field with new vistas for research. If the early findings are broadly found to be operative across many species, melatonin may have a fundamental role in identifying mates of the highest genetic quality. It would be important to document experimentally that males given melatonin to enhance their ornamental pigmentation are in fact more frequently selected as a sexual partner.
Because of its ability to detoxify oxygen-and nitrogenbased reactants, melatonin may have a role in reducing the likelihood of morphophysiologically flawed traits being passed to the next generation, as studies have preliminarily shown its ability to protect the gametes from oxidative and nitrosative damage [100, 101] . Moreover, based on the results of studies performed to date, melatonin should be further tested to determine if it would improve the outcome of IVF/ET procedures in humans and other species [85] . This would be of special significance given the high failure rate and cost of this procedure. Further investigations in this arena would have applicability to both human reproductive biology and veterinary medicine.
Finally, the actions of melatonin in protecting the placenta, fetus, and mother from oxidative damage due to a variety of toxic oxidizing events associated with pregnancy have obvious potential applications. Conditions in which clinical trials are indicated include the ability of melatonin to reduce the severity of preeclampsia and to limit damage to the placenta or fetus during transitory episodes of anoxia or hypoxia that are followed by reoxygenation. It is hypothesized that melatonin administered to treat these conditions would reduce the associated free radical damage, as shown in a small number of published studies [125] [126] [127] .
Melatonin is an uncommonly safe molecule that lacks demonstrable toxicity even when given in exceptionally high doses ( 200 mg/kg daily) throughout pregnancy [129] . Moreover, it may even enhance early embryonic development if the results of early studies prove to be correct [149, 150] .
